New Key Statistics Module, Z-Score and F-Score
NYSE:HAE Key Ratios
Market Cap $ M | 4,794.21 |
Enterprise Value $ M | 5,470.82 |
P/E(ttm) | 38.37 |
PE Ratio without NRI | 33.55 |
Forward PE Ratio | 21.93 |
Price/Book | 5.08 |
Price/Sales | 3.82 |
Price/Free Cash Flow | 37.59 |
Price/Owner Earnings | 62.48 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,270.00 |
EPS (TTM) $ | 2.46 |
Beneish M-Score | -2.4 |
10-y EBITDA Growth Rate % | 9.30 |
5-y EBITDA Growth Rate % | 6.80 |
y-y EBITDA Growth Rate % | 12.80 |
EV-to-EBIT | 32.14 |
EV-to-EBITDA | 20.75 |
PEG | 4.93 |
Shares Outstanding M | 50.79 |
Net Margin (%) | 9.97 |
Operating Margin % | 14.19 |
Pre-tax Margin (%) | 12.68 |
Quick Ratio | 1.76 |
Current Ratio | 2.92 |
ROA % (ttm) | 6.34 |
ROE % (ttm) | 14.73 |
ROIC % (ttm) | 8.80 |
Dividend Yield % | -- |
Altman Z-Score | 3.61 |
HAE Number of Guru Trades
HAE Volume of Guru Trades
Gurus Latest Trades with NYSE:HAE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:HAE is held by these investors
Total 3
Haemonetics Corp Insider Transactions
No Available Data
News about NYSE:HAE
Total 0- 1